Production and N-glycan engineering of Varlilumab in Nicotiana benthamiana
暂无分享,去创建一个
[1] R. Perneczky,et al. Anti-amyloid antibody therapies in Alzheimer's disease. , 2023, Brain : a journal of neurology.
[2] J. Reichert,et al. Antibodies to watch in 2023 , 2022, mAbs.
[3] R. Rappuoli,et al. Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana , 2022, Frontiers in Plant Science.
[4] B. Pulendran,et al. Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates , 2022, Cellular & molecular immunology.
[5] R. Reski,et al. Unexpected Arabinosylation after Humanization of Plant Protein N-Glycosylation , 2021, bioRxiv.
[6] K. Miura,et al. Transient protein expression systems in plants and their applications. , 2021, Plant biotechnology.
[7] N. Dey,et al. Engineering of Plants for Efficient Production of Therapeutics , 2021, Molecular Biotechnology.
[8] R. Misaki,et al. Production of Human Acid-Alpha Glucosidase With a Paucimannose Structure by Glycoengineered Arabidopsis Cell Culture , 2021, Frontiers in Plant Science.
[9] H. Yoshida,et al. Prevention of necrosis caused by transient expression in Nicotiana benthamiana by application of ascorbic acid. , 2021, Plant physiology.
[10] T. Pisitkun,et al. Structural and In Vitro Functional Analyses of Novel Plant-Produced Anti-Human PD1 Antibody , 2019, Scientific Reports.
[11] Lai-Xi Wang,et al. Glycoengineering of Antibodies for Modulating Functions. , 2019, Annual review of biochemistry.
[12] T. Kaley,et al. ATIM-23. ANTI-CD27 AGONIST ANTIBODY VARLILUMAB IN COMBINATION WITH NIVOLUMAB FOR RECURRENT GLIOBLASTOMA (rGBM): PHASE 2 CLINICAL TRIAL RESULTS , 2018, Neuro-Oncology.
[13] K. Tsumoto,et al. Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized Column , 2018, Scientific Reports.
[14] H. Steinkellner,et al. Promoter Choice Impacts the Efficiency of Plant Glyco‐Engineering , 2018, Biotechnology journal.
[15] L. Vitale,et al. CD27-Mediated Regulatory T Cell Depletion and Effector T Cell Costimulation Both Contribute to Antitumor Efficacy , 2017, The Journal of Immunology.
[16] P. Rudd,et al. Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy , 2017, Protein & Cell.
[17] J. Nemunaitis,et al. Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Yucheng Wang,et al. An Improved Syringe Agroinfiltration Protocol to Enhance Transformation Efficiency by Combinative Use of 5-Azacytidine, Ascorbate Acid and Tween-20 , 2017, Plants.
[19] Ajit Varki,et al. Biological roles of glycans , 2016, Glycobiology.
[20] Y. Dorokhov,et al. Plant factories for the production of monoclonal antibodies , 2016, Biochemistry (Moscow).
[21] S. Werner,et al. Engineering of complex protein sialylation in plants , 2016, Proceedings of the National Academy of Sciences.
[22] H. Kiyono,et al. Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants , 2015, Plant Cell Reports.
[23] T. Hackl,et al. Glycan modulation and sulfoengineering of anti–HIV-1 monoclonal antibody PG9 in plants , 2015, Proceedings of the National Academy of Sciences.
[24] F. Altmann,et al. Characterization of plants expressing the human β1,4-galactosyltrasferase gene , 2015, Plant physiology and biochemistry : PPB.
[25] J. Strong,et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp™ , 2014, Nature.
[26] G. Rouwendal,et al. Expression of natural human β1,4-GalT1 variants and of non-mammalian homologues in plants leads to differences in galactosylation of N-glycans , 2014, Transgenic Research.
[27] Jaeyoung Cho,et al. Reuse of hydroponic waste solution , 2014, Environmental Science and Pollution Research.
[28] L. Herrera-Estrella,et al. An improved, low-cost, hydroponic system for growing Arabidopsis and other plant species under aseptic conditions , 2014, BMC Plant Biology.
[29] N. Matoba,et al. Monoclonal Antibody Purification (Nicotiana benthamiana Plants). , 2014, Bio-protocol.
[30] S. Omaye,et al. Comparative Study of Ascorbic Acid and Tocopherol Concentrations in Hydroponic- and Soil-Grown Lettuces , 2013 .
[31] Jonathan Hurtado,et al. Agroinfiltration as an Effective and Scalable Strategy of Gene Delivery for Production of Pharmaceutical Proteins , 2013, Advanced techniques in biology & medicine.
[32] A. L. Rivera,et al. Physical methods for genetic plant transformation. , 2012, Physics of life reviews.
[33] S. Ansell,et al. Development of a Human Monoclonal Antibody for Potential Therapy of CD27-Expressing Lymphoma and Leukemia , 2012, Clinical Cancer Research.
[34] O. Bohorov,et al. Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody , 2011, PloS one.
[35] Johannes S. Gach,et al. Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12 , 2010, The Journal of Immunology.
[36] Michael D. McLean,et al. Plant-produced trastuzumab inhibits the growth of HER2 positive cancer cells. , 2010, Journal of agricultural and food chemistry.
[37] P. Lerouge,et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. , 2009, Plant biotechnology journal.
[38] R. Kunert,et al. Improved Virus Neutralization by Plant-produced Anti-HIV Antibodies with a Homogeneous β1,4-Galactosylated N-Glycan Profile* , 2009, The Journal of Biological Chemistry.
[39] C. Hawes,et al. Arginine/Lysine Residues in the Cytoplasmic Tail Promote ER Export of Plant Glycosylation Enzymes , 2008, Traffic.
[40] G. Lomonossoff,et al. Extremely High-Level and Rapid Transient Protein Production in Plants without the Use of Viral Replication1 , 2008, Plant Physiology.
[41] J. Stadlmann,et al. A Unique β1,3-Galactosyltransferase Is Indispensable for the Biosynthesis of N-Glycans Containing Lewis a Structures in Arabidopsis thaliana[W][OA] , 2007, The Plant Cell Online.
[42] Chris Hawes,et al. Plant N-Glycan Processing Enzymes Employ Different Targeting Mechanisms for Their Spatial Arrangement along the Secretory Pathway[W][OA] , 2006, The Plant Cell Online.
[43] R. Van Ree,et al. An antibody produced in tobacco expressing a hybrid β-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[44] N. Perrimon,et al. Functional genomics reveals genes involved in protein secretion and Golgi organization , 2006, Nature.
[45] P. Lerouge,et al. Recombinant anti-hCG antibodies retained in the endoplasmic reticulum of transformed plants lack core-xylose and core-alpha(1,3)-fucose residues. , 2004, Plant biotechnology journal.
[46] T. Nilsson,et al. Cisternal maturation and vesicle transport: join the band wagon! (Review) , 2003, Molecular membrane biology.
[47] P. Lerouge,et al. Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] E. Jokitalo,et al. Matrix proteins can generate the higher order architecture of the Golgi apparatus , 2000, Nature.
[49] S. Yoshida,et al. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[50] P. Wojtaszek. Oxidative burst: an early plant response to pathogen infection. , 1997, The Biochemical journal.